NASA’s Mars Sample Return program faces opposition from planetary scientists following proposed cancellation, with concerns raised over Perseverance samples, future Mars missions, and international ...

Jan 05, 2026 // Heading into 2026, the geopolitical and global governance short–term outlooks look perilous. Yet many ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

The United States military has quietly locked in a sweeping artificial intelligence partnership with Elon Musk's startup xAI, ...

Industry Analysis Examines Eight-Ingredient Powdered Formula, Nitric Oxide Pathway Research, and Age-Specific Circulatory ...

The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.

The global respiratory disease vaccine market size was valued at USD 65.72 billion in 2025 and is predicted to hit around USD ...

Market expert David Li reveals 10 strategic insights showing how Syngenta Group’s long bet on China is reshaping global ...

In this GEN webinar, our expert speakers will show how Nanoworx combines technical expertise with scalable workflows to support the seamless development of nanomedicines from early discovery and ...

Mars Sample Return is stalled as costs rise while China’s Tianwen-3 targets a 2031 return. Learn why this matters for science ...

ATRIMED today shared an update on a long running research effort led in part by physician scientist Dr. Latha Damle, whose ...